Aspiriant, LLC Vaneck ETF Tr Biotech ETF Transaction History

Aspiriant, LLC

$2.75 Billion
Q4 2024

A detailed history of Aspiriant, LLC transactions in Vaneck ETF Tr Biotech ETF stock. As of the latest transaction made, Aspiriant, LLC holds 4,333 shares of BBH stock, worth $716,894. This represents 0.02% of its overall portfolio holdings.

Number of Shares

4,333

Previous 4,333 -0.0%

Holding current value

$716,894

Previous $768,000 11.46%

% of portfolio

0.02%

Previous 0.03%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 15, 2024	SELL	$151.99 - $172.48 $11,399 - $12,936	-75 Reduced 1.7%	4,333 $729,000
Q1 2024 Apr 15, 2024	SELL	$159.3 - $170.6 $470,731 - $504,123	-2,955 Reduced 40.13%	4,408 $733,000
Q4 2023 Jan 26, 2024	SELL	$143.93 - $166.4 $5,757 - $6,656	-40 Reduced 0.54%	7,363 $1.22 Million
Q2 2023 Jul 19, 2023	SELL	$154.15 - $167.37 $27,747 - $30,126	-180 Reduced 2.37%	7,403 $1.16 Million
Q4 2022 Jan 23, 2023	BUY	$142.49 - $170.13 $421,057 - $502,734	2,955 Added 63.85%	7,583 $0
Q3 2022 Oct 28, 2022	SELL	$136.76 - $163.51 $3,282 - $3,924	-24 Reduced 0.52%	4,628 $656,000
Q2 2022 Jul 25, 2022	SELL	$132.48 - $167.33 $9,273 - $11,713	-70 Reduced 1.48%	4,652 $676,000
Q1 2022 May 06, 2022	SELL	$148.02 - $186.49 $28,419 - $35,806	-192 Reduced 3.91%	4,722 $765,000
Q4 2021 Feb 14, 2022	BUY	$182.1 - $202.87 $122,735 - $136,734	674 Added 15.9%	4,914 $932,000
Q3 2021 Oct 27, 2021	SELL	$195.25 - $220.75 $5,857 - $6,622	-30 Reduced 0.7%	4,240 $854,000
Q2 2021 Aug 13, 2021	BUY	$173.72 - $201.85 $13,897 - $16,148	80 Added 1.91%	4,270 $859,000
Q1 2021 May 11, 2021	SELL	$167.43 - $195.8 $27,291 - $31,915	-163 Reduced 3.74%	4,190 $733,000
Q4 2020 Feb 01, 2021	SELL	$152.3 - $177.17 $35,790 - $41,634	-235 Reduced 5.12%	4,353 $740,000
Q3 2020 Oct 29, 2020	SELL	$150.86 - $177.04 $10,409 - $12,215	-69 Reduced 1.48%	4,588 $743,000
Q2 2020 Aug 06, 2020	SELL	$124.43 - $164.89 $76,524 - $101,407	-615 Reduced 11.67%	4,657 $762,000
Q1 2020 May 05, 2020	SELL	$114.53 - $144.75 $102,160 - $129,117	-892 Reduced 14.47%	5,272 $673,000
Q4 2019 Jan 27, 2020	SELL	$114.81 - $142.85 $55,682 - $69,282	-485 Reduced 7.29%	6,164 $861,000
Q3 2019 Nov 04, 2019	SELL	$117.33 - $123.7 $130,353 - $137,430	-1,111 Reduced 14.32%	6,649 $785,000
Q2 2019 Aug 06, 2019	SELL	N/A	-754 Reduced 8.86%	7,760 $1 Million
Q1 2019 May 03, 2019	SELL	N/A	-929 Reduced 9.84%	8,514 $1.09 Million
Q4 2018 Feb 04, 2019	SELL	N/A	-749 Reduced 7.35%	9,443 $1.04 Million
Q3 2018 Oct 26, 2018	SELL	N/A	-435 Reduced 4.09%	10,192 $1.38 Million
Q2 2018 Aug 07, 2018	SELL	N/A	-773 Reduced 6.78%	10,627 $1.28 Million
Q1 2018 May 04, 2018	BUY	N/A	11,400 New	11,400 $1.37 Million
Q4 2017 Jan 31, 2018	SELL	N/A	-15,903 Closed	0 $0
Q3 2017 Nov 13, 2017	BUY	N/A	15,903	15,903 $2.13 Million

Others Institutions Holding BBH

# of Institutions

125

Shares Held

1.07M

Call Options Held

Put Options Held

View Full List

About VANECK ETF TR BIOTECH ETF

Ticker BBH
Sector ETFs
Industry ETFs

More about BBH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aspiriant, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aspiriant, LLC with notifications on news.

Account